Learning Objectives:
- Understand the importance of the development of the infant microbiome and the effect of feeding type on this development
- Assist the learner to understand the differences among the available human milk products and fortifiers
- Examine the evidence for the benefits of exclusively human milk-based products in VLBW babies in the NICU
- Be able to discuss the long-term benefits of the EHMD and some of the early data behind those outcomes
Speaker:
Melinda J Elliott, M.D., F.A.A.P.
Chief Medical Officer
Target Audience:
This 1 hour presentation is designed for the healthcare professional caring for premature infants.
